Clinical Trial

PICC-ports Versus Chest - Ports for Long Term Chemotherapy Deliverance in Oncology Patients

Study acronym: PICCHEST
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated November 19, 2024 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
Central venous access devices are extensively used in oncology patients. The current standard is represented by devices inserted by direct ultrasound guided cannulation of deep veins of supra/infraclavicular area with a reservoir placed in a subcutaneous pocket of the upper chest wall ("chest-ports"). More recently, PICC (Peripherally Inserted Central Catheters)-ports have been proposed as an alternative to chest-ports. Aim of this study is to demonstrate the non-inferiority of PICC ports compared to thoracic ports in terms of efficacy and safety.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06541301
Lead Sponsor European Institute of Oncology
Conditions Solid Tumor
Enrollment 852 participants
Start Date 2024-12
Primary Completion 2026-02 (estimated)
Study Completion 2026-02 (estimated)
Updated on ClinicalTrials.gov 2024-11-19